Literature DB >> 32361390

Enhanced Bax upregulating in mitochondria for deep tumor therapy based on SO2 prodrug loaded Au-Ag hollow nanotriangles.

Min Xu1, Qianglan Lu1, Yilin Song1, Lifang Yang1, Jining Li2, Nan Li3.   

Abstract

Nowadays, limited deep tumor penetration and lower therapeutic effect are still the major obstacle in nanomedicines for cancer therapy. Here, we developed high-efficiency nanocomposites, SO2 prodrug (BTS) loaded Au-Ag hollow nanotriangles (Au-Ag-BTS HTNs), which could not only synergistically upregulate Bax expression in mitochondria, but also be triggered by acidic tumor microenvironment to generate SO2 for deep tumor therapy. Upon NIR laser irradiation, Au-Ag hollow nanotriangles (Au-Ag HTNs) produced plenty of heat for photothermal therapy (PTT), while the acidic condition in tumor cells induced on-demand SO2 release from BTS for deep tumor therapy. More importantly, the combined therapy could simultaneously upregulate the expression of apoptosis factor Bax as well as downregulate Bcl-2 in mitochondria, which would induce an increase of Caspase-3 expression to accelerate the apoptosis of tumor cells, thereby achieving a win-win cooperation. The results indicated that enhanced deep tumor therapeutic effect based on Au-Ag-BTS HTNs was realized in vitro and in vivo. Such pH-triggered SO2 therapy offered a novel strategy for responding tumor microenvironment and improving penetration and heterogeneity distribution of nanotherapeutics in tumor.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Au-Ag hollow nanotriangles; Deep tumor therapy; Enhanced upregulating; Gas therapy; Sulfur dioxide prodrug

Mesh:

Substances:

Year:  2020        PMID: 32361390     DOI: 10.1016/j.biomaterials.2020.120076

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  1 in total

Review 1.  Near-infrared light-triggered nano-prodrug for cancer gas therapy.

Authors:  Runcong Liu; Yongjun Peng; Ligong Lu; Shaojun Peng; Tianfeng Chen; Meixiao Zhan
Journal:  J Nanobiotechnology       Date:  2021-12-23       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.